Update on the global polio situation and implications for the EU/EEA
According to the World Health Organization (WHO), one EU/EEA country (Romania) and two neighbouring countries (Bosnia and Herzegovina, and Ukraine) remain at high risk of a sustained polio outbreak partly due to insufficient vaccination coverage.
Know your status: get tested during European Testing Week
On the way towards the Sustainable Development Goal (SDG) for health, Europe has one important battle to take on: reducing the proportion of those living with undiagnosed HIV and viral hepatitis. Current status in the EU/EEA: one in seven people living with HIV are unaware of their infection, up to four out of 5 people living with hepatitis B and three out of four people with hepatitis C infection have not yet been diagnosed.
Flu Awareness Week, 21-25 October 2019
The Flu Awareness Week is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.
World Health Organization recommendations for the influenza virus vaccine composition for the 2020 southern hemisphere season
On September 2019, WHO has agreed on the recommended composition of the quadrivalent and trivalent influenza vaccines for the southern hemisphere 2020 influenza season.
Global Vaccination Summit
The European Commission organises, in cooperation with the World Health Organisation, a Global Vaccination Summit on 12 September 2019, in Brussels.
Travellers who recently received rabies post-exposure prophylaxis in Philippines advised to contact health services
The recommendation from ECDC follows reports of falsified rabies vaccines and anti-rabies serum circulating in the Philippines and is aimed at travellers who have received the vaccine or serum after possible exposure to rabies.
Targeted testing for viral hepatitis: Europe’s persistent public health challenge
Targeted testing is an essential element of any strategy to eliminate viral hepatitis across the countries in the European Union and European Economic Area. Some preliminary monitoring results on the response to hepatitis B and C presented around World Hepatitis Day show that diagnosing chronic infections is still a challenge in the EU/EEA.